Nitroprusside

MSDS Language: EN
Country:
                      **** MATERIAL SAFETY DATA SHEET ****

  Sodium Nitroprusside Dihydrate
30681

        **** SECTION 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION ****

MSDS Name: Sodium Nitroprusside Dihydrate
Catalog Numbers:
     S/5680, S/5720
Synonyms:
     Nipride dihydrate; Disodium nitroprusside dihydrate; Sodium
     nitroferricyanide dihydrate; Sodium nitrosylpentacyanoferrate(III)
     dih
Company Identification:  Fisher Scientific UK
                         Bishop Meadow Road
                         Loughborough, Leicestershire
                         LE11 5RG, UK
For information, call:   01509 231166
For emergencies, call:   01509 231166

          **** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****

+----------------+--------------------------------------+----------+-----------+-----------+---------------+
|      CAS#      |              Chemical Name           |    %     |  EINECS#  |Haz Symbols| Risk Phrases  |
|----------------|--------------------------------------|----------|-----------|-----------|---------------+
|----------------|--------------------------------------|----------|-----------|-----------|---------------|
|    13755-38-9  |Sodium nitroferricyanide dihydrate    |  >99.8   | 238-373-9 |||
|----------------|--------------------------------------|----------|-----------|-----------|---------------|
+----------------+--------------------------------------+----------+-----------+-----------+---------------+
          Text for R-phrases: see Section 16
          Hazard Symbols: T
          Risk Phrases: 23/24/25

                  **** SECTION 3 - HAZARDS IDENTIFICATION ****

                               EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if
swallowed.Hygroscopic (absorbs moisture from the air).

Potential Health Effects
     Eye:
          May cause eye irritation.
     Skin:
          May cause skin irritation. May be metabolized to cyanide which in
          turn acts by inhibiting cytochrome oxidase impairing cellular
          respiration.
     Ingestion:
          Metabolism may release cyanide, which may result in headache,
          dizziness, weakness, collapse, unconsciousness and possible death.
          Ingestion may result in symptoms similar to cyanide poisoning which
          is characterized by asphyxiation. Large doses of cyanide may result
          in suddden loss of consciousness and  prompt death; small doses will
          prolong the above symptoms 1 to 2 hours.
     Inhalation:
          May cause respiratory tract irritation. May be metabolized to
          cyanide which in turns act by inhibiting cytochrome oxidase
          impairing cellular respiration.
     Chronic:
          May be metabolized to cyanide which in turn acts by inhibiting
          cytochrome oxidase impairing cellular respiration. Chronic exposure
          to cyanide solutions may lead to the development of a "cyanide" rash,
          characterized by itching, and by macular, papular, and vesicular
          eruptions, and may be accompanied by secondary infections. Exposure
          to small amounts of cyanide compounds over long periods of time is
          reported to cause loss of appetite, headache, weakness, nausea,
          dizziness, and symptoms of irritation of the upper respiratory tract
          and eyes.

                    **** SECTION 4 - FIRST AID MEASURES ****

     Eyes:
          In case of contact, immediately flush eyes with plenty of water for
          at least 15 minutes. Get medical aid.
     Skin:
          In case of contact, immediately flush skin with plenty of water.
          Remove contaminated clothing and shoes. Get medical aid. Wash
          clothing before reuse.
     Ingestion:
          If swallowed, do not induce vomiting unless directed to do so by
          medical personnel. Never give anything by mouth to an unconscious
          person. Get medical aid.
     Inhalation:
          If inhaled, remove to fresh air. If not breathing, give artificial
          respiration. If breathing is difficult, give oxygen. Get medical aid.
     Notes to Physician:
     Antidote:
          Always have a cyanide antidote kit on hand when working with cyanide
          compounds. Get medical advice to use.

                  **** SECTION 5 - FIRE FIGHTING MEASURES ****

     General Information:
          As in any fire, wear a self-contained breathing apparatus in
          pressure-demand, MSHA/NIOSH (approved or equivalent), and full
          protective gear. During a fire, irritating and highly toxic gases
          may be generated by thermal decomposition or combustion. Combustion
          by-products include oxides of nitrogen and hydrogen cyanide.
     Extinguishing Media:
          Use extinguishing media most appropriate for the surrounding fire.

                **** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****

     General Information: Use proper personal protective equipment as indicated
                          in Section 8.
     Spills/Leaks:
          Clean up spills immediately, observing precautions in the Protective
          Equipment section. Sweep up, then place into a suitable container for
          disposal. Avoid generating dusty conditions. Provide ventilation.

                   **** SECTION 7 - HANDLING and STORAGE ****

     Handling:
          Wash thoroughly after handling. Remove contaminated clothing and
          wash before reuse. Minimize dust generation and accumulation. Avoid
          contact with eyes, skin, and clothing. Keep container tightly closed.
          Do not breathe dust. Use only with adequate ventilation.
     Storage:
          Store in a tightly closed container. Store in a cool, dry,
          well-ventilated area away from incompatible substances. Store
          protected from moisture.

          **** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****

     Engineering Controls:
          Facilities storing or utilizing this material should be equipped
          with an eyewash facility and a safety shower. Use adequate general or
          local exhaust ventilation to keep airborne concentrations below the
          permissible exposure limits.
     Personal Protective Equipment

                 Eyes:
                       Not available.
                 Skin:
                       Wear appropriate protective gloves to prevent skin
                       exposure.
             Clothing:
                       Wear appropriate protective clothing to prevent skin
                       exposure.
          Respirators:
                       A respiratory protection program that meets OSHA's 29
                       CFR 1910.134 and ANSI Z88.2 requirements or European
                       Standard EN 149 must be followed whenever workplace
                       conditions warrant a respirator's use.

             **** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****

Physical State:             Crystals
Color:                      bright red
Odor:                       practically odorless
pH:                         Not available.
Vapor Pressure:             Not available.
Viscosity:                  Not available.
Boiling Point:              Not available.
Freezing/Melting Point:     Not available.
Autoignition Temperature:   Not applicable.
Flash Point:                Not applicable.
Explosion Limits, lower:    Not available.
Explosion Limits, upper:    Not available.
Decomposition Temperature:
Solubility in water:        Soluble.
Specific Gravity/Density:   1.72 g/cm3
Molecular Formula:          C5FeN6O.Na2.2H2O
Molecular Weight:           215.8866

                 **** SECTION 10 - STABILITY AND REACTIVITY ****

     Chemical Stability:
          Stable under normal temperatures and pressures.
     Conditions to Avoid:
          Dust generation, excess heat, exposure to moist air or water.
     Incompatibilities with Other Materials:
          Strong oxidizing agents, strong acids.
     Hazardous Decomposition Products:
          Hydrogen cyanide, nitrogen oxides, irritating and toxic fumes and
          gases, sodium oxide.
     Hazardous Polymerization: Has not been reported

                **** SECTION 11 - TOXICOLOGICAL INFORMATION ****

     RTECS#:
          CAS# 13755-38-9: LJ8925000
          CAS# 14402-89-2: LJ8750000
     LD50/LC50:
          Not available.
          CAS# 14402-89-2: Oral, mouse: LD50 = 61 mg/kg; Oral, rabbit: LD50 =
          34 mg/kg; Oral, rat: LD50 = 99 mg/kg.
     Carcinogenicity:
       Sodium nitroferricyanide dihydrate -
          Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
       Sodium nitroferricyanide, anhydrous -
          Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
     Other:
          See actual entry in RTECS for complete information.

                  **** SECTION 12 - ECOLOGICAL INFORMATION ****



                 **** SECTION 13 - DISPOSAL CONSIDERATIONS ****

Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location.  Contact a specialist disposal company or the local
waste regulator for advice.  Empty containers must be decontaminated before
returning for recycling.

                  **** SECTION 14 - TRANSPORT INFORMATION ****

     IATA
          Shipping Name: Cyanides, Inorganic, Solid, N.O.S.
           Hazard Class: 6.1
              UN Number: 1588
          Packing Group: III
     IMO
          Shipping Name: Cyanides, Inorganic, Solid, N.O.S.Cyanides, Inorga
                         nic, Solid, N.O.S.
           Hazard Class: 6.1
              UN Number: 1588
          Packing Group: III
     RID/ADR
          Shipping Name: Cyanides, Inorganic, Solid, N.O.S.
           Hazard Class: 6.1
              UN Number: 1588
          Packing group: II

                  **** SECTION 15 - REGULATORY INFORMATION ****

 European/International Regulations
     European Labeling in Accordance with EC Directives
          Hazard Symbols: T
          Risk Phrases:
                       R 23/24/25  Toxic by inhalation, in contact with skin
                       and if swallowed.
          Safety Phrases:
                       S 28A  After contact with skin, wash immediately with
                       plenty of water.
                       S 36/37/39  Wear suitable protective clothing, gloves
                       and eye/face protection.
                       S 38  In case of insufficient ventilation, wear
                       suitable respiratory equipment.
                       S 45  In case of accident or if you feel unwell, seek
                       medical advice immediately (show the label where
                       possible).
   WGK (Water Danger/Protection)
          CAS# 13755-38-9: 2
          CAS# 14402-89-2: No information available.
   United Kingdom Occupational Exposure Limits

   United Kingdom Maximum Exposure Limits

   Canada
          CAS# 14402-89-2 is listed on Canada's DSL List.
          CAS# 13755-38-9 is not listed on Canada's Ingredient Disclosure List.
          CAS# 14402-89-2 is not listed on Canada's Ingredient Disclosure List.
   Exposure Limits
 US FEDERAL
     TSCA
          CAS# 13755-38-9 is not on the TSCA Inventory because it is a hydrate.
          It is considered to be listed if the CAS number for the anhydrous form
          is on the inventory (40CFR720.3(u)(2)).
          CAS# 14402-89-2 is listed on the TSCA inventory.

                  **** SECTION 16 - ADDITIONAL INFORMATION ****

     MSDS Creation Date:  6/23/2004  Revision #0 Date: Original.

     The information above is believed to be accurate and represents the best
     information currently available to us. However, we make no warranty of
     merchantability or any other warranty, express or implied, with respect to
     such information, and we assume no liability resulting from its use. Users
     should make their own investigations to determine the suitability of the
     information for their particular purposes. In no way shall the company be
     liable for any claims, losses, or damages of any third party or for lost
     profits or any special, indirect, incidental, consequential or exemplary
     damages, howsoever arising, even if the company has been advised of
     the possibility of such damages.
--------------------------------------------------------------------------------